Qiaojun Fang
| Title： |
Professor |
| E-mail： |
fangqj(AT)nanoctr.cn |
| Affiliation： |
National Center for Nanoscience and Technology (NCNST)
No.11 Beiyitiao Zhongguancun,
100190 Beijing,
P. R. China |
| Group Webpage： |
http://www.nanoctr.cn/qiaojunfang/ |
Education and Professional Experience:
2/2013 to current Principle Investigator, National Center for Nanoscience and Technology, Beijing, China
7/2009 to 1/2013 Staff scientist, Fred Hutchinson Cancer Research Center, Seattle, WA
2/2007 to 6/2009 Post-doctoral fellow, Fred Hutchinson Cancer Research Center, Seattle, WA
10/2005 to 1/2007 Post-doctoral fellow, Department of Biological Chemistry at the Johns Hopkins University School of Medicine, Baltimore, MD
Ph. D. 2005 Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD, USA
M.S. 1999 Biochemistry Department, Peking University, Beijing, P. R. China
B.S. 1996 Department of Plant Physiology and Molecular Biology, Peking University, Beijing, P. R. China
1. Yimin Zou#, Bin Tu#, Lanlan Yu, Yongfang Zheng,Yuchen Lin, Wendi Luo, Yanlian Yang*, Qiaojun Fang* and Chen Wang*, “Peptide conformation and oligomerization characteristics of surface-mediated assemblies revealed by molecular dynamics simulations and scanning tunneling microscopy”, RSC Adv., 2019, 9, 41345.
2. Zhichu Xiang, Gexuan Jiang, Xiaoliang Yang, Di Fan , Xiaohui Nan, Dan Li , Zhiyuan Hu* and Qiaojun Fang* ,“Peptosome Coadministration Improves Nanoparticle Delivery to Tumors through NRP1-Mediated Co-Endocytosis”, Biomolecules, 2019, 9(5), 172.
3. Xiaoliang Yang#, Yan Zhang#, Wenjia Lai#, Zhichu Xiang, Bin Tu, Dan Li, Xiaohui Nan, Chunying Chen*, Zhiyuan Hu*, and Qiaojun Fang*, “Proteomic profiling of RAW264.7 macrophage cells exposed to graphene oxide: insights into acute cellular responses”, Nanotoxicology,2019 Feb;13(1):35-49. DOI: 10.1080/17435390.2018.1530389.
4. Zhichu Xiang, Xiaoliang Yang, Junjie Xu, Wenjia Lai, Zihua Wang, Zhiyuan Hu*,Jiesheng Tian*, Lingling Geng*,Qiaojun Fang*, “Tumor Detection Using Magnetosome Nanoparticles Functionalized with A Newly Screened EGFR/HER2 Targeting Peptide”, Biomaterials, 2017 Jan 16;115:53-64.
5. Lingling Geng#, Zihua Wang#, Xiangqian Jia, Qiuju Han, Zhichu Xiang, Dan Li, Xiaoliang Yang, Di Zhang,Xiangli Bu, Weizhi Wang*, Zhiyuan Hu*, and Qiaojun Fang*, “HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery”, Theranostics, 2016, May 28 6(8): 1261–1273.
